Abstract
Antitumor vaccine is a promising strategy for the treatment of cancer by using tumor antigens capable of activating and/or improving the individual's immune system. However, it is necessary to identify tumor antigens and overcome the immunosuppressive tumor microenvironment to generate the desired immune response. The epidermal growth factor receptor variant III (EGFRvIII) is associated w…